1614 / 1631
RT in CNS leukemia
•
Rarely used as prophylaxis in ALL
•
Considered for overt CNS leukemia at diagnosis
or relapse, especially when other CNS directed
therapy has failed
•
Considered for ALL or AML pts. undergoing
allogeneic transplant and have a history of CNS
involvement